ATE396177T1 - Neue kristalline formen eines faktor xa inhibitors - Google Patents
Neue kristalline formen eines faktor xa inhibitorsInfo
- Publication number
- ATE396177T1 ATE396177T1 AT01979459T AT01979459T ATE396177T1 AT E396177 T1 ATE396177 T1 AT E396177T1 AT 01979459 T AT01979459 T AT 01979459T AT 01979459 T AT01979459 T AT 01979459T AT E396177 T1 ATE396177 T1 AT E396177T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitor
- factor
- crystalline forms
- new crystalline
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23831600P | 2000-10-05 | 2000-10-05 | |
| GBGB0108903.6A GB0108903D0 (en) | 2000-10-05 | 2001-04-10 | Novel crystalline forms of a factor Xa inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396177T1 true ATE396177T1 (de) | 2008-06-15 |
Family
ID=22897372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01979459T ATE396177T1 (de) | 2000-10-05 | 2001-10-04 | Neue kristalline formen eines faktor xa inhibitors |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7034160B2 (de) |
| EP (1) | EP1326838B1 (de) |
| JP (1) | JP4177663B2 (de) |
| AT (1) | ATE396177T1 (de) |
| AU (2) | AU1142502A (de) |
| CA (1) | CA2424565C (de) |
| CY (1) | CY1108224T1 (de) |
| DK (1) | DK1326838T3 (de) |
| ES (1) | ES2304396T3 (de) |
| GB (1) | GB0108903D0 (de) |
| IL (1) | IL155189A (de) |
| MX (1) | MXPA03002067A (de) |
| PT (1) | PT1326838E (de) |
| WO (1) | WO2002028836A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6964784B2 (en) * | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
| EA025572B1 (ru) | 2011-03-29 | 2017-01-30 | Санофи | Лекарственные формы отамиксабана с улучшенной стабильностью |
| ES2539236T3 (es) * | 2011-03-29 | 2015-06-29 | Sanofi | Sal de ácido benzoico de Otamixaban |
| TWI551289B (zh) * | 2011-03-29 | 2016-10-01 | 賽諾菲公司 | 具有改良之安定性之奧米沙班調配物 |
| CN104736178A (zh) | 2012-06-04 | 2015-06-24 | 药品循环公司 | 布鲁顿酪氨酸激酶抑制剂的晶形 |
| SG11201700849XA (en) | 2014-08-07 | 2017-03-30 | Pharmacyclics Llc | Novel formulations of a bruton's tyrosine kinase inhibitor |
| JP7149076B2 (ja) | 2015-03-03 | 2022-10-06 | ファーマサイクリックス エルエルシー | ブルトン型チロシンキナーゼ阻害剤の薬学的製剤 |
| MA41827A (fr) * | 2015-03-27 | 2018-01-30 | Pharmacyclics Llc | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080767A (en) * | 1996-01-02 | 2000-06-27 | Aventis Pharmaceuticals Products Inc. | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| HU228355B1 (en) * | 1996-01-02 | 2013-03-28 | Aventis Pharma Inc | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
-
2001
- 2001-04-10 GB GBGB0108903.6A patent/GB0108903D0/en not_active Ceased
- 2001-10-04 EP EP01979459A patent/EP1326838B1/de not_active Expired - Lifetime
- 2001-10-04 AU AU1142502A patent/AU1142502A/xx active Pending
- 2001-10-04 MX MXPA03002067A patent/MXPA03002067A/es active IP Right Grant
- 2001-10-04 AT AT01979459T patent/ATE396177T1/de active
- 2001-10-04 JP JP2002532422A patent/JP4177663B2/ja not_active Expired - Fee Related
- 2001-10-04 PT PT01979459T patent/PT1326838E/pt unknown
- 2001-10-04 ES ES01979459T patent/ES2304396T3/es not_active Expired - Lifetime
- 2001-10-04 DK DK01979459T patent/DK1326838T3/da active
- 2001-10-04 CA CA2424565A patent/CA2424565C/en not_active Expired - Fee Related
- 2001-10-04 WO PCT/US2001/031087 patent/WO2002028836A1/en active Application Filing
- 2001-10-04 AU AU2002211425A patent/AU2002211425B2/en not_active Ceased
-
2003
- 2003-04-01 US US10/404,678 patent/US7034160B2/en not_active Expired - Lifetime
- 2003-04-01 IL IL155189A patent/IL155189A/en not_active IP Right Cessation
-
2008
- 2008-07-29 CY CY20081100790T patent/CY1108224T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2304396T3 (es) | 2008-10-16 |
| JP2004521082A (ja) | 2004-07-15 |
| DK1326838T3 (da) | 2008-09-22 |
| CA2424565A1 (en) | 2002-04-11 |
| EP1326838A1 (de) | 2003-07-16 |
| GB0108903D0 (en) | 2001-05-30 |
| AU2002211425B2 (en) | 2006-03-02 |
| MXPA03002067A (es) | 2003-06-24 |
| IL155189A (en) | 2011-11-30 |
| JP4177663B2 (ja) | 2008-11-05 |
| CY1108224T1 (el) | 2014-02-12 |
| AU1142502A (en) | 2002-04-15 |
| CA2424565C (en) | 2011-04-26 |
| PT1326838E (pt) | 2008-07-08 |
| WO2002028836A9 (en) | 2003-11-20 |
| US20030225144A1 (en) | 2003-12-04 |
| WO2002028836A1 (en) | 2002-04-11 |
| US7034160B2 (en) | 2006-04-25 |
| EP1326838B1 (de) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| CA2441313A1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| DE69907963D1 (de) | Heteroaromatische amide als inhibitoren von faktor xa | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| AP1744A (en) | Inhibitors of factor XA and other serine proteases involved in the coagulation cascade | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| DE60229530D1 (de) | Substituierte piperazine als modulatoren des melanocortinrezeptors | |
| DE60236102D1 (en) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
| ATE374765T1 (de) | Substituierte heterocyclische amide | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| EA200501268A1 (ru) | Ингибирующие вич 1,2,4-триазины | |
| UY27991A1 (es) | Derivados de pirrolidona domo inhibidores de maob | |
| CY1108224T1 (el) | Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα | |
| SE0403171D0 (sv) | New compounds | |
| ATE380174T1 (de) | Arginin-mimetika als faktor xa-inhibitoren | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| DE60229420D1 (de) | Neue metallproteinaseinhibitoren | |
| RS94603A (en) | Novel compounds and compositions as cathepsin inhibitors | |
| DE60114640D1 (en) | Antithrombosemittel | |
| DE60121804D1 (de) | Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin | |
| HUP0400976A2 (hu) | VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek | |
| ATE501127T1 (de) | Neue cysteinproteasehemmer und ihre therapeutische anwendung | |
| MXPA03002493A (es) | Proceso eficiente para preparacion de un inhibidor del factor xa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1326838 Country of ref document: EP |